Transcranial Electrical Stimulation (tES) is a promising non-invasive brain modulation tool. Over the past years, there have been several attempts to modulate sleep with tES-based approaches in both ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor ...

Sleep apnea occurs when a person’s breathing repeatedly stops and starts during the night, causing them to wake again and ...

Ichiro Suzuki becomes first Asian player elected to the Baseball Hall of Fame This Medical AI Stock Is Up 39% After Launch of Personal Health App Live updates: Trump pardons Jan. 6 rioters and signs ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

You may have heard that frequent snoring is a sign of sleep apnea. It's true that snoring is one of the most common symptoms. But not everyone who has sleep apnea snores. And of course ...

Menopause is a significant phase in women's health, in which the incidence of obstructive sleep apnea (OSA) is significantly increased. Body fat distribution changes with age and hormone levels in ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the ...